Table 1.
Age, gender and comorbidities of the patients included in this study.
| Overall patients(n = 113) | Patients with allergic disorders (n = 24) | Other patients(n = 89) | Intergroup comparison values | |
|---|---|---|---|---|
| Age (mean ± SD); range | 67.62 ± 16.05; 28-99 | 59.21 ± 16.21; 28-86 | 69.89 ± 15.32; 29-99 | P = 0.0031 |
| Gender (women/men) | 56/57 | 14/10 | 42/47 | P = 0.3332 |
| Comorbidity excluding asthma or allergy, (yes/no) | 93/20 | 16/8 | 77/12 | P = 0.0242 |
| Antecedents of hypertension, (yes/no) | 61/52 | 8/16 | 53/36 | P = 0.0222 |
| Antecedents of heart diseases, (yes/no) | 28/85 | 7/17 | 21/68 | P = 0.5752 |
| Antecedents of dyslipidemia, (yes/no) | 27/86 | 2/22 | 25/64 | P = 0.0442 |
| Antecedents of type II diabetes, (yes/no) | 25/88 | 2/22 | 23/66 | P = 0.0672 |
| Antecedents of renal diseases, (yes/no) | 20/93 | 0/24 | 20/69 | P = 0.0102 |
| Antecedents of prothrombotic disorders, (yes/no) | 18/95 | 7/17 | 11/78 | P = 0.0462 |
| Antecedents of respiratory diseases3, (yes/no) | 15/98 | 3/21 | 12/77 | P = 0.9002 |
| Antecedents of cerebrovascular diseases, (yes/no) | 13/100 | 2/22 | 11/78 | P = 0.5832 |
| Antecedents of cognitive impairment, (yes/no) | 13/100 | 2/22 | 11/78 | P = 0.5832 |
| Antecedents of psychiatric diseases, (yes/no) | 11/102 | 2/22 | 9/80 | P = 0.7942 |
| Antecedents of hormonal disorders, (yes/no) | 11/102 | 1/23 | 10/79 | P = 0.3002 |
| Antecedents of neurological diseases, (yes/no) | 10/103 | 2/22 | 8/81 | P = 0.9202 |
| Antecedents of digestive diseases, (yes/no) | 10/103 | 1/23 | 9/80 | P = 0.3632 |
| Antecedents of neoplastic diseases, (yes/no) | 10/103 | 0/24 | 10/79 | P = 0.0852 |
| Antecedents of morbid obesity, (yes/no) | 8/105 | 2/22 | 6/83 | P = 0.7872 |
| Antecedents of anaemia, (yes/no) | 7/106 | 1/23 | 6/83 | P = 0.6422 |
1T-test for independent samples.
2Pearson’s Chi-square test.
3Patients with asthma were excluded from this group.